0

Venous Thromboembolism Collection
 21-40 of 65 Articles
ACP Journal Club |  19 March 2013
Aspirin did not reduce recurrence after a first-ever, unprovoked venous thromboembolism
Thomas DeLoughery, MD, FACP, FAWM
Ann Intern Med. 2013;158(6):JC2. doi:10.7326/0003-4819-158-6-201303190-02002
ACP Journal Club |  19 March 2013
Scores poorly predict major bleeding (c-statistics ≤ 0.61) during oral anticoagulant therapy
Richard H. White, MD
Ann Intern Med. 2013;158(6):JC13. doi:10.7326/0003-4819-158-6-201303190-02013
ACP Journal Club |  19 February 2013
A weighted risk index had moderate ability to predict VTE requiring treatment after outpatient surgery
Juan I. Arcelus, MD, PhD
Ann Intern Med. 2013;158(4):JC12. doi:10.7326/0003-4819-158-4-201302190-02012
ACP Journal Club |  16 October 2012
Aspirin reduced recurrence of venous thromboembolism (VTE) after a first-ever, unprovoked VTE
Ian Rabinowitz, MD
Ann Intern Med. 2012;157(8):JC4-3. doi:10.7326/0003-4819-157-8-201210160-02003
ACP Journal Club |  16 October 2012
Contraceptive transdermal patches or vaginal rings were associated with increased venous thrombosis
Andra H. James, MD, MPH
Ann Intern Med. 2012;157(8):JC4-10. doi:10.7326/0003-4819-157-8-201210160-02010
ACP Journal Club |  18 September 2012
Review: New oral anticoagulants reduced stroke and systemic embolism compared with warfarin in AF
Liviu Klein, MD, MS
Ann Intern Med. 2012;157(6):JC3-2. doi:10.7326/0003-4819-157-6-201209180-02002
ACP Journal Club |  21 August 2012
Review: Fondaparinux reduces VTE and recurrence in superficial thrombophlebitis of the leg
Scott M. Stevens, MD
Ann Intern Med. 2012;157(4):JC2-4. doi:10.7326/0003-4819-157-4-201208210-02004
ACP Journal Club |  21 August 2012
Review: Factor Xa inhibitors reduce DVT more than LMWH in total knee or hip replacement
Robert Bona, MD, FACP
Ann Intern Med. 2012;157(4):JC2-5. doi:10.7326/0003-4819-157-4-201208210-02005
ACP Journal Club |  21 August 2012
Rivaroxaban and usual care had similar rates of recurrent VTE and bleeding in symptomatic PE
Daniel M. Witt, PharmD, FCCP, BCPS
Ann Intern Med. 2012;157(4):JC2-6. doi:10.7326/0003-4819-157-4-201208210-02006
ACP Journal Club |  21 August 2012
Warfarin and aspirin did not differ for death or stroke in heart failure and sinus rhythm
Tariq Ahmad, MD, MPH; G. Michael Felker, MD, MHS
Ann Intern Med. 2012;157(4):JC2-7. doi:10.7326/0003-4819-157-4-201208210-02007
ACP Journal Club |  21 February 2012
Review: VTE prophylaxis in nonsurgical inpatients reduces PE but not death, and increases major bleeding
Andrew L. Freeman, MD; Robert C. Pendleton, MD
Ann Intern Med. 2012;156(4):JC2-5. doi:10.7326/0003-4819-156-4-201202210-02005
ACP Journal Club |  17 January 2012
Review: Gestalt or clinical decision rules have limited sensitivity and specificity for detecting acute PE
Scott M. Stevens, MD
Ann Intern Med. 2012;156(2):JC1-11. doi:10.7326/0003-4819-156-2-201201170-02011
ACP Journal Club |  18 October 2011
Outpatient treatment was noninferior to inpatient treatment for preventing recurrent VTE in low-risk patients with acute PE
Shannon M. Bates, MD; Gordon H. Guyatt, MD
Ann Intern Med. 2011;155(8):JC4-2. doi:10.7326/0003-4819-155-8-201110180-02002
ACP Journal Club |  20 September 2011
4 clinical decision rules plus D-dimer testing each had high sensitivity and low specificity for excluding acute pulmonary embolism
Andrew Dunn, MD, FACP, SFHM
Ann Intern Med. 2011;155(6):JC3-11. doi:10.7326/0003-4819-155-6-201109200-02011
ACP Journal Club |  19 July 2011
Dalteparin did not differ from unfractionated heparin for reducing proximal DVT in critically ill patients
David A. Garcia, MD
Ann Intern Med. 2011;155(2):JC1-7. doi:10.7326/0003-4819-155-2-201107190-02007
ACP Journal Club |  21 June 2011
The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care
Alfonso Iorio, MD
Ann Intern Med. 2011;154(12):JC6-13. doi:10.7326/0003-4819-154-12-201106210-02013
ACP Journal Club |  17 May 2011
Rivaroxaban was noninferior to enoxaparin for preventing short-term recurrent VTE and superior to placebo in continued treatment
James Douketis, MD
Ann Intern Med. 2011;154(10):JC5-6. doi:10.7326/0003-4819-154-10-201105170-02006
ACP Journal Club |  17 May 2011
Apixaban reduced VTE and did not increase major bleeding compared with enoxaparin in hip replacement
James Douketis, MD
Ann Intern Med. 2011;154(10):JC5-7. doi:10.7326/0003-4819-154-10-201105170-02007
ACP Journal Club |  15 February 2011
Fondaparinux reduced a composite of VTE complications or death in superficial leg-vein thrombosis
Walter Ageno, MD
Ann Intern Med. 2011;154(4):JC2-3. doi:10.7326/0003-4819-154-4-201102150-02003
ACP Journal Club |  18 January 2011
Review: Positive D-dimer results predict recurrence after first unprovoked VTE regardless of test timing or cutpoint, or patient age
Daniel M. Witt, PharmD, FCCP, BCPS, CACP
Ann Intern Med. 2011;154(2):JC1-5. doi:10.7326/0003-4819-154-2-201101180-02005
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)